Clinical Study of Cannabidiol in Children and Adolescents With Fragile X Syndrome

Condition:   Fragile X Syndrome Interventions:   Drug: ZYN002 - CBD transdermal gel;   Drug: Placebo Sponsor:   Zynerba Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials